A procedure is described to utilize blue dextran-Sepharose as an affinity chromatographic column specific for the super-secondary structure called the dinucleotide fold, which forms the binding sites for substrates and effectors on a wide range of proteins. The procedure can be used to identify proteins, either purified or in crude cellular extracts, that possess the dinucleotide fold and to significantly improve the purification procedures for those proteins that possess the fold.
A sulfonated polyaromatic blue dye covalently attached to dextran, called blue dextran, O-DEXTRAN is commonly used to measure the void volume of exclusion chromatographic columns. It has been observed that several proteins that normally penetrate the internal volume of exclusion gel beads are totally excluded from the internal volume when chromatographed along with blue dextran in the presence of low, but not high, ionic strength solvents. A variety of proteins exhibit this behavior, such as pyruvate kinase (1, 2) , glutathione reductase (3) , and blood coagulation factors II, VII, IX, and X (4). It was concluded that blue dextran forms a complex with each of these proteins that is dissociable by salt. Subsequent to these observations, blue dextran-Sepharose affinity columns have been made and used in the final purification stages of enzymes such as phosphofructokinase (5) and lactate dehydrogenase (6) .
These enzymes were displaced from the affinity columns by addition of low concentrations of their nucleotide substrates to the elution solvents.
We propose that the blue dextran complexes with this wide range of proteins because it is specific for a super-secondary structure called the dinucleotide fold. This structure involves about 120 amino acids that are arranged in a ,-sheet core composed of five or six parallel strands connected by ahelical intrastrand loops located above and below the ,8-sheet (7, 8) . The dinucleotide fold is known to form the NADbinding site in lactate (9) , malate (10) , and glyceraldehydephosphate (11) dehydrogenases, to form the ATP-binding site in phosphoglycerate kinase (12) , and to be present in the structures of alcohol dehydrogenase (13), adenylate kinase (14, 15) , and phosphoglycerate mutase (16) . In addition, the FMN-binding site of flavodoxin (17, 18) and the aromatic specificity site in the proteolytic enzyme subtilisin (19, 20) have been proposed (7, 8) to contain a remnant of the dinucleotide fold termed the mononucleotide fold. Accordingly, we examined the interaction of blue dextran-Sepharose affinity columns with each of these proteins as well as with several proteins known not to possess the dinucleotide fold to determine the specificity of the affinity columns.
MATERIALS AND METHODS
Crystalline suspensions of rabbit muscle phosphoglycerate mutase, yeast 6-phosphogluconate dehydrogenase, yeast hexokinase, bovine pancreatic ribonuclease, type I-A, horse heart ferricytochrome c, type VI, rabbit muscle M4 lactate dehydrogenase, and pig heart citrate synthetase were purchased from the Sigma Chemical Co. Rabbit muscle glyceraldehyde phosphate dehydrogenase, pig heart malate dehydrogenase, rabbit muscle adenylate kinase, and yeast 3-phosphoglycerate kinase were obtained from Boehringer Mannheim. Staphylococcus aureus nuclease was obtained from the Worthington Biochemical Corp. Subtilisin Novo was purchased from Novo Industrai, Japan. Purified samples of horse liver alcohol dehydrogenase, Peptostreptococcus eledenii flavodoxin, rabbit muscle fructose diphosphatase, Streptococcus faecium dihydrofolate reductase, Escherichia coli DNA polymerase, and Ascaris lumbricordee malonyl CoA carboxylase were kindly provide by Drs. Bryce Plapp, Martha Ludwig, Arthur Arnone, Raymond Blakley, John Donelson, and Richard Tkachuck, respectively. Apoflavodoxin was prepared from flavodoxin using the procedure described by Mayhew (21) . Cyanogen bromide-activated Sepharose 4B and blue dextran were obtained from Pharmacia. The activated Sepharose was derivatized with blue dextran using the procedure described by Ryan and Vestling (6) .
A series of blue dextran-Sepharose microcolumns were constructed, each having the dimensions of 0.6 X 3 cm and having a solvent volume of about 1 ml. These columns were equilibrated with 10 mM Tris-HCl buffer (pH 7.5 at room temperature). About 500 jg of a given purified protein, dialyzed against the same buffer, was applied to each of several blue dextran-Sepharose microtulip columns. The columns were then washed with at least five 1-ml volumes of Trise HCl buffer. If no protein absorbance or enzymic activity was detected in the column effluent, one column was eluted with the Tris-HCl buffer containing 1 M NaCl. Additional columns were eluted batchwise with five to ten 1-nml volumes 669 Table 1 , all proteins known to possess the dinucleotide fold bind to blue dextran affinity columns. Each of these proteins is rapidly and quantitatively eluted from the affinity columns by the presence of either a low (1-10 mM) concentration of nucleotide ligand or a high concentration (1000 mM) of NaCl in the equilibration solvent. In each case, the nucleotide ligand that is known to have the highest affinity for the enzyme is most effective in eluting the bound enzyme. For example, solvents containing 1 mM NADH readily elute lactate dehydrogenase, while solvents containing 10 mM NAD, AMP, ADP, or ATP do not (Fig. 1A) . Binding (22) and inhibition (23) measurements indicate that the affinity of lactate dehydrogenase for NADH is about three orders of magnitude greater than that for NAD and about four orders greater than that for ATP, ADP, or AMP. The presence of a concentration of NaCl in excess of 100 mM is necessary to rapidly elute lactate dehydrogenase from the affinity columns in the absence of any nucleotide.
If blue dextran is specific for the dinucleotide fold, it should be a competitive inhibitor for the nucleotide ligands that are known to bind to the fold. The effect of free blue dextran on the catalytic activity of lactate dehydrogenase and of phosphoglycerate kinase is shown in Fig. 2 . Computer-assisted analyses of the experimental values obtained with each enzyme demonstrate a superior fit with the equation for competitive, as opposed to noncompetitive, inhibition. The K1 of about 10-10 M calculated for the blue chromophore-lactate dehydrogenase complex indicates that the chromophore has a very strong affinity for a dinucleotide fold specific for the dinucleotide NADH. As shown in Fig. 3 , the blue chromophore can assume a conformation that mimics the orientation of the aromatic rings and anionic groups characteristic of NAD (24) as it binds to the dinucleotide fold of dehydrogenases. The K1 of about 2 juM measured for the blue chromophore-phosphoglycerate kinase complex indicates that the chromophore has a lower affinity for a dinucleotide fold specific for a mononucleotide ATP.
If blue dextran columns are specific for the dinucleotide fold, then proteins that bind nucleotides but do not have the fold would not be expected to interact with the columns. Three proteins known to possess these properties were examined, Staphylococcal nuclease (25, 26) , ribonuclease (27, 28) , and cytochrome c (29, 30) . As shown in Table 1 The column labeled "pI" lists the isoelectric point or isoionic point for the proteins as reported in the appropriate volumes of The Enzymes. The column labeled "Ligand" lists the nucleotide substrate, cofactor, effector, or substrate analog that is expected to have the lowest value for KM, K,, or KD under the conditions used. The column labeled "Bound" indicates whether the protein binds to blue dextran-Sepharose affinity columns in the presence of 10 mM Tris * HOC buffer (pH 7.5). The column labeled "Eluant" refers to the compound added to the buffer that was found most effective in eluting each protein.
* Affinity chromatography using ribonuclease was done in 10 mM acetate buffer (pH 5.5) since the ligand 2'-CMP binds most strongly at this pH (28 apoflavodoxin do not bind to the affinity columns even though they each contain a remnant of the dinucleotide fold.
We have also examined the affinity of blue dextran for several enzymes whose structures are not known in detail. We regard binding of a given enzyme to the column and elution of the enzyme by low concentrations of specific nucleotide ligands as evidence for the presence of the dinucleotide fold. Results are shown in Table 1 . We conclude that the NADP site of 6-phosphogluconate dehydrogenase is formed by the fold, while that of dihydrofolate reductase is not. Similarly, the ATP site in phosphofructokinase is formed by the dinucleotide fold but the ATP site in hexokinase is not. The low-resolution crystallographic structure of hexokinase also gives no evidence for the presence of the fold (31). These results indicate that at least two distinctly different conformations have evolved that bind the same nucleotide ligand. As shown in Table 1 , DNA polymerase also contains the dinucleotide fold. Preliminary measurements with two enzymes specific for coenzyme A, citrate synthetase and malonyl CoA transferase, suggest that these proteins also contain the fold.
Nucleotide-specific allosteric sites as well as substrate sites can be formed by the dinucleotide fold. As shown in Table 1 , fructosediphosphatase binds to the affinity columns and is eluted by solvents containing 1 mM of the positive effector, 5'-AMP. Since the substrate for this enzyme is a hexosediphosphate, it is unlikely that the low concentration of AMP used results in significant binding to the catalytic site.
We have also used a blue dextran affinity column to significantly improve the purification of phosphofructokinase from E. coli. Present purification (32, 33) procedures require seven or eight steps and result in about a 35% recovery of enzyme.
By contrast, the procedure illustrated in Table 2 requires only two steps and results in a recovery of over 75%. The product has the specific activity characteristic of purified E. coli phosphofructokinase and migrates as a single component during polyacrylamide electrophoresis at several pH values. In this case, the relative affinity of blue dextran and ATP for the dinucleotide fold on phosphofructokinase, together with dehydrogenases (24) . The structure of the blue chromophore shown on the right is oriented to mimic that of NAD. Note that two of the sulfate groups of the blue chromophore are positioned similarly to the two phosphate groups in NAD. Four hundred grams of E. coli cell paste were homogenized in 10 mM Tris -HCH buffer (pH 7.5). The particulate matter was removed by centrifugation and the supernatant was applied to a 1 X 15-cm blue dextran-Sepharose column equilibrated with the Tris buffer. The column was washed with the Tris buffer and then eluted with the Tris buffer containing a linear gradient between 0 and 0.1 mM ATP. The protein eluted from the column under these conditions was resolved into three components. Phosphofructokinase activity was all associated with the major component containing 25 mg of protein and centered at 25 /AM ATP. all that is required to establish the presence of the fold is a crude cellular extract in a low ionic strength solvent and an assay for the biological activity of the protein of interest. If the biological activity is missing from the crude extract after passage over the affinity column and if specific ligands are more effective than nonspecific, e.g., NaCl, compounds in recovering the activity, it is very likely that the protein possesses the dinucleotide fold. This procedure should facilitate rapid screening of a wide range of proteins for the occurrence of the dinucleotide fold and represents a distinct advantage over the much more stringent requirements of the alternative but more definitive procedure of x-ray crystallography.
The large capacity of our blue dextran-Sepharose for protein and the potential selectivity of gradient elution with specific ligands suggest that blue dextran affinity chromatography is potentially very useful to abbreviate established protein purification procedures, to improve yields, and by rapid processing, to minimize losses due to proteolytic contaminants or inherent instability. In some instances, batch elution with one or more ligands followed by gradient elution with the ligand specific for the protein of interest may be advantageous.
